Filing
Spy
Filing
Spy
Home
About
GILD — Gilead Sciences, Inc. - FilingSpy
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
5 holders
Ownership
Activity
Fundamentals
2020 Q4
21 of 52 quarters
Total Value
$661.31M
Total Shares
11.35M
Net Share Change
+3.15M
Activity
4 buying
1 selling
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$639.67M
10.98M
0.9%
ADD
+3.11M
(+39.5%)
Dodge & Cox Stock Fund
$639.67M
10.98M shares
ADD
+3.11M
(+39.5%)
Matrix Asset Advisors
$17.50M
300.3K
3.0%
ADD
+24.4K
(+8.8%)
Matrix Asset Advisors
$17.50M
300.3K shares
ADD
+24.4K
(+8.8%)
Bridgewater Associates LP
$2.95M
50.6K
0.0%
NEW
Bridgewater Associates LP
$2.95M
50.6K shares
NEW
Maverick Capital
$604.0K
10.4K
0.0%
TRIM
-35.0K
(-77.1%)
Maverick Capital
$604.0K
10.4K shares
TRIM
-35.0K
(-77.1%)
Pzena Investment Management
$587.0K
10.1K
0.0%
ADD
+2.0K
(+24.3%)
Pzena Investment Management
$587.0K
10.1K shares
ADD
+2.0K
(+24.3%)